Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Canntab Therapeutics granted cannabis research licence from Health Canada

1 minute reading time (255 words)

viewCanntab Therapeutics Ltd

Canntab Therapeutics Limited (CSE:PILL-OTCQB: CTABF) Co-Founder and CFO Richard Goldstein joined Steve Darling from Proactive Vancouver on Skype to discuss the company being granted their cannabis research license from Health Canada. Goldstein talks about what this license allows Canntab to do and what their next step is.

Goldstein also told Proactive what the company plan on for the remainder of 2020. 

CSE:PILL

Market: CSE
Market Cap: $12.65 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Full interview: Exactus clinches two supply agreements

Exactus Inc (OTCMKTS:EXDI) CEO Emiliano Aloi tells Proactive it has entered into a supply and distribution agreement with Ceed2Med, as well as supplying hemp to Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF). Aloi says its an exciting venture and expects to push its products with...

on 11/26/2019

2 min read


Related Posts


MjInvest.com